Proteomic Analysis of Early Mid-Trimester Amniotic Fluid Does Not Predict Spontaneous Preterm Delivery
Jazyk angličtina Země Spojené státy americké Médium electronic-ecollection
Typ dokumentu hodnotící studie, časopisecké články
PubMed
27214132
PubMed Central
PMC4876998
DOI
10.1371/journal.pone.0155164
PII: PONE-D-15-39144
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- druhý trimestr těhotenství metabolismus MeSH
- lidé MeSH
- mladý dospělý MeSH
- novorozenec MeSH
- plodová voda chemie metabolismus MeSH
- předčasná porodní činnost diagnóza metabolismus MeSH
- předčasný porod diagnóza metabolismus MeSH
- prenatální diagnóza metody MeSH
- prognóza MeSH
- proteom analýza metabolismus MeSH
- proteomika MeSH
- studie případů a kontrol MeSH
- těhotenství MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- novorozenec MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- hodnotící studie MeSH
- Názvy látek
- proteom MeSH
OBJECTIVE: The aim of this study was to identify early proteomic biomarkers of spontaneous preterm delivery (PTD) in mid-trimester amniotic fluid from asymptomatic women. METHODS: This is a case-cohort study. Amniotic fluid from mid-trimester genetic amniocentesis (14-19 weeks of gestation) was collected from 2008 to 2011. The analysis was conducted in 24 healthy women with subsequent spontaneous PTD (cases) and 40 randomly selected healthy women delivering at term (controls). An exploratory phase with proteomics analysis of pooled samples was followed by a verification phase with ELISA of individual case and control samples. RESULTS: The median (interquartile range (IQR: 25th; 75th percentiles) gestational age at delivery was 35+5 (33+6-36+6) weeks in women with spontaneous PTD and 40+0 (39+1-40+5) weeks in women who delivered at term. In the exploratory phase, the most pronounced differences were found in C-reactive protein (CRP) levels, that were approximately two-fold higher in the pooled case samples than in the pooled control samples. However, we could not verify these differences with ELISA. The median (25th; 75th IQR) CRP level was 95.2 ng/mL (64.3; 163.5) in women with spontaneous PTD and 86.0 ng/mL (51.2; 145.8) in women delivering at term (p = 0.37; t-test). CONCLUSIONS: Proteomic analysis with mass spectrometry of mid-trimester amniotic fluid suggests CRP as a potential marker of spontaneous preterm delivery, but this prognostic potential was not verified with ELISA.
Biomedical Research Center University Hospital Hradec Kralove Hradec Kralove Czech Republic
Centro de Investigaciones Biomedicas en Enfermedades Raras Barcelona Spain
Department of Neurochemistry Sahlgrenska University Hospital Gothenburg Sweden
Department of Obstetrics and Gynecology Sahlgrenska University Hospital Gothenburg Sweden
Mathematical Sciences Chalmers University of Technology Gothenburg Sweden
Zobrazit více v PubMed
Bryce J, Boschi-Pinto C, Shibuya K, Black RE. WHO estimates of the causes of death in children. Lancet. 2005;365(9465):1147–52. PubMed
Goldenberg RL, Andrews WW, Hauth JC. Choriodecidual infection and preterm birth. Nutrition reviews. 2002;60(5 Pt 2):S19–25. PubMed
Woodward LJ, Moor S, Hood KM, Champion PR, Foster-Cohen S, Inder TE, et al. Very preterm children show impairments across multiple neurodevelopmental domains by age 4 years. Archives of disease in childhood Fetal and neonatal edition. 2009;94(5):F339–44. 10.1136/adc.2008.146282 PubMed DOI
Morken NH, Kallen K, Hagberg H, Jacobsson B. Preterm birth in Sweden 1973–2001: rate, subgroups, and effect of changing patterns in multiple births, maternal age, and smoking. Acta obstetricia et gynecologica Scandinavica. 2005;84(6):558–65. PubMed
Kacerovsky M, Lenco J, Musilova I, Tambor V, Lamont R, Torloni MR, et al. Proteomic biomarkers for spontaneous preterm birth: a systematic review of the literature. Reproductive sciences. 2014;21(3):283–95. 10.1177/1933719113503415 PubMed DOI
Dasilva N, Diez P, Matarraz S, Gonzalez-Gonzalez M, Paradinas S, Orfao A, et al. Biomarker discovery by novel sensors based on nanoproteomics approaches. Sensors. 2012;12(2):2284–308. 10.3390/s120202284 PubMed DOI PMC
Kacerovsky M, Andrys C, Drahosova M, Musilova I, Hornychova H, Lesko D, et al. Soluble Toll-like receptor 1 family members in the amniotic fluid of women with preterm prelabor rupture of the membranes. The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2012;25(9):1699–704. PubMed
Buhimschi CS, Bhandari V, Hamar BD, Bahtiyar MO, Zhao G, Sfakianaki AK, et al. Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS medicine. 2007;4(1):e18 PubMed PMC
Buhimschi CS, Dulay AT, Abdel-Razeq S, Zhao G, Lee S, Hodgson EJ, et al. Fetal inflammatory response in women with proteomic biomarkers characteristic of intra-amniotic inflammation and preterm birth. BJOG: an international journal of obstetrics and gynaecology. 2009;116(2):257–67. PubMed PMC
Buhimschi IA, Christner R, Buhimschi CS. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG: an international journal of obstetrics and gynaecology. 2005;112(2):173–81. PubMed
Romero R, Espinoza J, Gotsch F, Kusanovic JP, Friel LA, Erez O, et al. The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome. BJOG: an international journal of obstetrics and gynaecology. 2006;113 Suppl 3:118–35. PubMed PMC
Romero R, Kusanovic JP, Gotsch F, Erez O, Vaisbuch E, Mazaki-Tovi S, et al. Isobaric labeling and tandem mass spectrometry: a novel approach for profiling and quantifying proteins differentially expressed in amniotic fluid in preterm labor with and without intra-amniotic infection/inflammation. The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2010;23(4):261–80. PubMed PMC
Klein J, Buffin-Meyer B, Mullen W, Carty DM, Delles C, Vlahou A, et al. Clinical proteomics in obstetrics and neonatology. Expert review of proteomics. 2014;11(1):75–89. 10.1586/14789450.2014.872564 PubMed DOI
Buhimschi IA, Zhao G, Rosenberg VA, Abdel-Razeq S, Thung S, Buhimschi CS. Multidimensional proteomics analysis of amniotic fluid to provide insight into the mechanisms of idiopathic preterm birth. PloS one. 2008;3(4):e2049 10.1371/journal.pone.0002049 PubMed DOI PMC
Fotopoulou C, Kyeyamwa S, Linder M, Thieme D, Hartenstein S, Klein O, et al. Proteomic analysis of midtrimester amniotic fluid to identify novel biomarkers for preterm delivery. The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2012;25(12):2488–93. PubMed
Mercer BM, Crouse DT, Goldenberg RL, Miodovnik M, Mapp DC, Meis PJ, et al. The antibiotic treatment of PPROM study: systemic maternal and fetal markers and perinatal outcomes. American journal of obstetrics and gynecology. 2012;206(2):145 e1-9. PubMed PMC
Tambor V, Fucikova A, Lenco J, Kacerovsky M, Rehacek V, Stulik J, et al. Application of proteomics in biomarker discovery: a primer for the clinician. Physiological research / Academia Scientiarum Bohemoslovaca. 2010;59(4):471–97. PubMed
Tambor V, Kacerovsky M, Lenco J, Bhat G, Menon R. Proteomics and bioinformatics analysis reveal underlying pathways of infection associated histologic chorioamnionitis in pPROM. Placenta. 2013;34(2):155–61. 10.1016/j.placenta.2012.11.028 PubMed DOI
Vuadens F, Benay C, Crettaz D, Gallot D, Sapin V, Schneider P, et al. Identification of biologic markers of the premature rupture of fetal membranes: proteomic approach. Proteomics. 2003;3(8):1521–5. PubMed
Gravett MG, Novy MJ, Rosenfeld RG, Reddy AP, Jacob T, Turner M, et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA: the journal of the American Medical Association. 2004;292(4):462–9. PubMed
Ruetschi U, Rosen A, Karlsson G, Zetterberg H, Rymo L, Hagberg H, et al. Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation. Journal of proteome research. 2005;4(6):2236–42. PubMed
Bea JW, Wright NC, Thompson P, Hu C, Guerra S, Chen Z. Performance evaluation of a multiplex assay for future use in biomarker discovery efforts to predict body composition. Clinical chemistry and laboratory medicine: CCLM / FESCC. 2011;49(5):817–24. PubMed PMC
Tambor V, Kacerovsky M, Andrys C, Musilova I, Hornychova H, Pliskova L, et al. Amniotic fluid cathelicidin in PPROM pregnancies: from proteomic discovery to assessing its potential in inflammatory complications diagnosis. PloS one. 2012;7(7):e41164 10.1371/journal.pone.0041164 PubMed DOI PMC
Zhou Y, Cras-Meneur C, Ohsugi M, Stormo GD, Permutt MA. A global approach to identify differentially expressed genes in cDNA (two-color) microarray experiments. Bioinformatics. 2007;23(16):2073–9. PubMed
Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. The New England journal of medicine. 1999;340(6):448–54. PubMed
Ghezzi F, Franchi M, Raio L, Di Naro E, Bossi G, D'Eril GV, et al. Elevated amniotic fluid C-reactive protein at the time of genetic amniocentesis is a marker for preterm delivery. American journal of obstetrics and gynecology. 2002;186(2):268–73. PubMed
Gomez R, Ghezzi F, Romero R, Munoz H, Tolosa JE, Rojas I. Premature labor and intra-amniotic infection. Clinical aspects and role of the cytokines in diagnosis and pathophysiology. Clinics in perinatology. 1995;22(2):281–342. PubMed
Borna S, Mirzaie F, Abdollahi A. Mid-trimester amniotic fluid C-reactive protein, ferritin and lactate dehydrogenase concentrations and subsequent risk of spontaneous preterm labour. Aust N Z J Obstet Gynaecol. 2009;49(4):400–3. 10.1111/j.1479-828X.2009.01019.x PubMed DOI
Kim A, Lee ES, Shin JC, Kim HY. Identification of biomarkers for preterm delivery in mid-trimester amniotic fluid. Placenta. 2013. PubMed
Ozer KT, Kavak ZN, Gokaslan H, Elter K, Pekin T. Predictive power of maternal serum and amniotic fluid CRP and PAPP-A concentrations at the time of genetic amniocentesis for the preterm delivery. European journal of obstetrics, gynecology, and reproductive biology. 2005;122(2):187–90. PubMed
Tarim E, Bagis T, Kilicdag EB, Sezgin N, Yanik F. Are amniotic fluid C-reactive protein and glucose levels, and white blood cell counts at the time of genetic amniocentesis related with preterm delivery? Journal of perinatal medicine. 2005;33(6):524–9. PubMed
Lee SM, Park JS, Norwitz ER, Oh S, Kim EJ, Kim SM, et al. Mid-trimester amniotic fluid pro-inflammatory biomarkers predict the risk of spontaneous preterm delivery in twins: a retrospective cohort study. Journal of perinatology: official journal of the California Perinatal Association. 2015. PubMed